FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2925208582> ?p ?o ?g. }

• W2925208582 endingPage "e14967" @default.
• W2925208582 startingPage "e14967" @default.
• W2925208582 abstract "Abstract Background: Recent studies have shown the efficacy for using spironolactone to treat heart failure with reduced ejection fraction (HFrEF), but the efficacy of spironolactone for heart failure with mid-range ejection fraction (HFmrEF) and heart failure with preserved ejection fraction (HFpEF) is unclear. This meta-analysis investigated the efficacy and safety of spironolactone in patients with HFmrEF and HFpEF. Methods and results: We searched several databases including PubMed and the Cochrane Collaboration, for randomized controlled trials (RCTs) that assessed spironolactone treatment in HFmrEF and HFpEF. Eleven RCTs including 4539 patients were included. Spironolactone reduced hospitalizations (odds ratio [OR], 0.84; 95% confidence interval [CI], 0.73–0.95; P = .006), improved New York Heart Association functional classifications (NYHA-FC) (OR, 0.35; 95% CI, 0.19–0.66; P = .001), decreased the levels of brain natriuretic peptide (BNP) (mean difference [MD], − 44.80 pg/mL; 95% CI, −73.44–−16.17; P = .002), procollagen type I C-terminal propeptide (PICP) (MD, −27.04 ng/mL; 95% CI, −40.77–−13.32, P < .001) in HFmrEF and HFpEF. Besides, it improved 6-minute walking distances (6-MWD) (standard weighted mean difference [SMD], 0.45 m; 95% CI, 0.27–0.64; P < .001), decreased amino-terminal peptide of procollagen type-III (PIIINP) (SMD, −0.37 μg/L; 95% CI, −0.59–−0.15; P = .001) in HFpEF only. The risks of hyperkalemia ( P <.001) and gynecomastia ( P <.001) were increased. Conclusion: Patients with HFmrEF and HFpEF could benefit from spironolactone treatment, with reduced hospitalizations, BNP levels, improved NYHA-FC, alleviated myocardial fibrosis by decreasing serum PICP in HFmrEF and HFpEF, decreased PIIINP levels and increased 6-MWD only in HFpEF. The risks of hyperkalemia and gynecomastia were significantly increased with the spironolactone treatment." @default.
• W2925208582 created "2019-04-01" @default.
• W2925208582 creator A5001728683 @default.
• W2925208582 creator A5009178917 @default.
• W2925208582 creator A5020681544 @default.
• W2925208582 creator A5047119592 @default.
• W2925208582 creator A5083352330 @default.
• W2925208582 creator A5086113944 @default.
• W2925208582 creator A5086897850 @default.
• W2925208582 creator A5088564463 @default.
• W2925208582 creator A5090471152 @default.
• W2925208582 date "2019-03-01" @default.
• W2925208582 modified "2023-10-11" @default.
• W2925208582 title "Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction" @default.
• W2925208582 cites W1617328014 @default.
• W2925208582 cites W1818378016 @default.
• W2925208582 cites W1883738259 @default.
• W2925208582 cites W1999321766 @default.
• W2925208582 cites W2002737854 @default.
• W2925208582 cites W2038163008 @default.
• W2925208582 cites W2041254742 @default.
• W2925208582 cites W2060297801 @default.
• W2925208582 cites W2098767714 @default.
• W2925208582 cites W2102779499 @default.
• W2925208582 cites W2105400632 @default.
• W2925208582 cites W2113829060 @default.
• W2925208582 cites W2143839402 @default.
• W2925208582 cites W2152072062 @default.
• W2925208582 cites W2164852092 @default.
• W2925208582 cites W2178738676 @default.
• W2925208582 cites W2187526770 @default.
• W2925208582 cites W2289998940 @default.
• W2925208582 cites W2291286562 @default.
• W2925208582 cites W2296999486 @default.
• W2925208582 cites W2333741822 @default.
• W2925208582 cites W2412266927 @default.
• W2925208582 cites W2427094903 @default.
• W2925208582 cites W2505489639 @default.
• W2925208582 cites W2539412725 @default.
• W2925208582 cites W2742547292 @default.
• W2925208582 cites W2748529467 @default.
• W2925208582 cites W2765710635 @default.
• W2925208582 cites W4293860347 @default.
• W2925208582 doi "https://doi.org/10.1097/md.0000000000014967" @default.
• W2925208582 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6456096" @default.
• W2925208582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30921200" @default.
• W2925208582 hasPublicationYear "2019" @default.
• W2925208582 type Work @default.
• W2925208582 sameAs 2925208582 @default.
• W2925208582 citedByCount "23" @default.
• W2925208582 countsByYear W29252085822019 @default.
• W2925208582 countsByYear W29252085822020 @default.
• W2925208582 countsByYear W29252085822021 @default.
• W2925208582 countsByYear W29252085822022 @default.
• W2925208582 countsByYear W29252085822023 @default.
• W2925208582 crossrefType "journal-article" @default.
• W2925208582 hasAuthorship W2925208582A5001728683 @default.
• W2925208582 hasAuthorship W2925208582A5009178917 @default.
• W2925208582 hasAuthorship W2925208582A5020681544 @default.
• W2925208582 hasAuthorship W2925208582A5047119592 @default.
• W2925208582 hasAuthorship W2925208582A5083352330 @default.
• W2925208582 hasAuthorship W2925208582A5086113944 @default.
• W2925208582 hasAuthorship W2925208582A5086897850 @default.
• W2925208582 hasAuthorship W2925208582A5088564463 @default.
• W2925208582 hasAuthorship W2925208582A5090471152 @default.
• W2925208582 hasBestOaLocation W29252085821 @default.
• W2925208582 hasConcept C126322002 @default.
• W2925208582 hasConcept C156957248 @default.
• W2925208582 hasConcept C164705383 @default.
• W2925208582 hasConcept C207103383 @default.
• W2925208582 hasConcept C2775915353 @default.
• W2925208582 hasConcept C2776379505 @default.
• W2925208582 hasConcept C2777099384 @default.
• W2925208582 hasConcept C2778198053 @default.
• W2925208582 hasConcept C44249647 @default.
• W2925208582 hasConcept C71924100 @default.
• W2925208582 hasConcept C78085059 @default.
• W2925208582 hasConceptScore W2925208582C126322002 @default.
• W2925208582 hasConceptScore W2925208582C156957248 @default.
• W2925208582 hasConceptScore W2925208582C164705383 @default.
• W2925208582 hasConceptScore W2925208582C207103383 @default.
• W2925208582 hasConceptScore W2925208582C2775915353 @default.
• W2925208582 hasConceptScore W2925208582C2776379505 @default.
• W2925208582 hasConceptScore W2925208582C2777099384 @default.
• W2925208582 hasConceptScore W2925208582C2778198053 @default.
• W2925208582 hasConceptScore W2925208582C44249647 @default.
• W2925208582 hasConceptScore W2925208582C71924100 @default.
• W2925208582 hasConceptScore W2925208582C78085059 @default.
• W2925208582 hasIssue "13" @default.
• W2925208582 hasLocation W29252085821 @default.
• W2925208582 hasLocation W29252085822 @default.
• W2925208582 hasLocation W29252085823 @default.
• W2925208582 hasLocation W29252085824 @default.
• W2925208582 hasOpenAccess W2925208582 @default.
• W2925208582 hasPrimaryLocation W29252085821 @default.
• W2925208582 hasRelatedWork W2051712573 @default.
• W2925208582 hasRelatedWork W2061321770 @default.
• W2925208582 hasRelatedWork W2187526770 @default.

• next